Artelo Biosciences (ARTL) Q1 2026 Earnings
ARTL·Reported May 14, 2026·Before market open
Diluted EPS came in at $-4.00 (+7.4% YoY), missed the $-0.78 consensus by $3.22.
Diluted EPS
$-4.00missed by $3.22
Consensus: $-0.78
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Artelo Biosciences's Q1 2026 earnings report.
Artelo Biosciences (ARTL) reported Q1 2026 earnings on May 14, 2026 before market open.
Artelo Biosciences reported diluted EPS of $-4.00 for Q1 2026.
EPS missed the consensus estimate of $-0.78 by $3.22.
Compared to the same quarter a year prior, diluted EPS grew 7.4% from $-4.32.
You can read the 8-K earnings release (0001640334-26-000903) and the 10-Q periodic report (0001640334-26-000869) directly on SEC EDGAR. The filing index links above go to sec.gov.